Diabetes Market Research Reports & Industry Analysis
Glucose monitors have a major consumer-marketing component. While physicians may prescribe a monitor, the patient ultimately has the choice of which monitor s/he uses. Insulin provides very little consumer choice. The treatment regimen prescribed by the physician must be followed and there are very few market options. With Eli Lilly and Novo Nordisk being the two largest producers of insulin, it is highly likely that an insulin user will wind up using one of their products. As time goes by, the options of oral insulin and more intranasal insulin products may offer insulin dependent diabetics more variety in terms of products and delivery methods.
Hypoglycemic agents abound and vary in their composition and mode of action. For the most part, advanced cases of Type 2 diabetes require more than one of these drugs in order for the patient to maintain glycemic control. Because of the wide variety of these products, there is some room for pharmaceutical companies to influence diabetics toward using their products. In the end, the physician may have the last word, but that does not mean that the patient will stay with a physician who does not acquiesce to his/her wishes.
Diabetes Industry Research & Market Reports
-
Asia-Pacific Diabetic Footwear Market Outlook, 2029
... diabetic footwear due to growing disposable incomes and growing awareness of healthcare issues. For manufacturers and healthcare providers, this offers profitable potential. Over 400 million people in the Asia-Pacific area, or over half of all ... Read More
-
Generic Drugs Market Report by Therapy Area (Central Nervous System, Cardiovascular, Dermatology, Genitourinary/Hormonal, Respiratory, Rheumatology, Diabetes, Oncology, and Others), Drug Delivery (Oral, Injectables, Dermal/Topical, Inhalers), Distribution Channel (Retail Pharmacies, Hospital Pharmacies), and Country 2024-2032
... global generic drugs market size reached US$ 367.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 628.0 Billion by 2032, exhibiting a growth rate (CAGR) of 5.96% during 2024-2032. The ... Read More
-
Diabetic Footwear Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)
... billion by 2029, growing at a CAGR of 6.28% during the forecast period (2024-2029). Globally, the diabetic footwear market is witnessing a significant growth rate owing to rising awareness among diabetic patients regarding the health ... Read More
-
Global Insulin Delivery Pen Market Size, Growth, Trends, Share and Forecast 2024 – 2032
... USD 28.7 Billion in 2032, expanding at a CAGR 5.5% during the forecast period. The most important factors expected to contribute to the growth of the global diabetes insulin delivery pen market: Growing Prevalence of ... Read More
-
Middle East & Africa In-Vitro Diagnostics Market Forecast to 2030 – Regional Analysis – by Product & Services (Reagents & Kits, Instruments, and Software & Services), Technology (Immunoassay/ Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Microbiology, Blood Glucose Self-Monitoring, Coagulation & Hemostasis, Hematology, Urinalysis, and Others), Application (Infectious Diseases, Diabetes, Oncology, Cardiology, Autoimmune Diseases, Nephrology, and Others), and End User (Hospitals, Laboratories, Homecare, and Others)
... Glucose Self-Monitoring, Coagulation & Hemostasis, Hematology, Urinalysis, and Others), Application (Infectious Diseases, Diabetes, Oncology, Cardiology, Autoimmune Diseases, Nephrology, and Others), and End User (Hospitals, Laboratories, Homecare, and Others) The Middle East & Africa in-vitro diagnostics ... Read More
-
Peripheral Neuropathy Market Report: Trends, Forecast and Competitive Analysis to 2030
... center markets. The global peripheral neuropathy market is expected to grow with a CAGR of 7.0% from 2024 to 2030. The major drivers for this market are surge in geriatric and obese population and increasing ... Read More
-
South & Central America In-Vitro Diagnostics Market Forecast to 2030 – Regional Analysis – by Product & Services (Reagents & Kits, Instruments, and Software & Services), Technology (Immunoassay/ Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Microbiology, Blood Glucose Self-Monitoring, Coagulation & Hemostasis, Hematology, Urinalysis, and Others), Application (Infectious Diseases, Diabetes, Oncology, Cardiology, Autoimmune Diseases, Nephrology, and Others), and End User (Hospitals, Laboratories, Homecare, and Others)
... Glucose Self-Monitoring, Coagulation & Hemostasis, Hematology, Urinalysis, and Others), Application (Infectious Diseases, Diabetes, Oncology, Cardiology, Autoimmune Diseases, Nephrology, and Others), and End User (Hospitals, Laboratories, Homecare, and Others) The South & Central America in-vitro diagnostics ... Read More
-
Asia Pacific In-Vitro Diagnostics Market Forecast to 2030 – Regional Analysis – by Product & Services (Reagents & Kits, Instruments, and Software & Services), Technology (Immunoassay/ Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Microbiology, Blood Glucose Self-Monitoring, Coagulation & Hemostasis, Hematology, Urinalysis, and Others), Application (Infectious Diseases, Diabetes, Oncology, Cardiology, Autoimmune Diseases, Nephrology, and Others), and End User (Hospitals, Laboratories, Homecare, and Others)
... Coagulation & Hemostasis, Hematology, Urinalysis, and Others), Application (Infectious Diseases, Diabetes, Oncology, Cardiology, Autoimmune Diseases, Nephrology, and Others), and End User (Hospitals, Laboratories, Homecare, and Others) The Asia Pacific in-vitro diagnostics market is expected to ... Read More
-
Global Diabetes Management Devices Market 2024-2028
... diabetes management devices market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current ... Read More
-
Digital Therapeutics (DTx) Market by Offerings (Platform, Virtual Reality/Games), Revenue Model (Subscription, Value Based), Application (Therapy (Diabetes, Obesity, CNS, Respiratory, CVD), Drug Adherence, Rehab/Patient care) - Global Forecast to 2028
... projected to reach USD 21.9 billion by 2028 from USD 6.1 billion in 2023, at a CAGR of 29.1% during the forecast period. The rapid adoption of digital therapeutics is driven by factors such as ... Read More
-
Insulin biosimilars Global Market Report 2024
... Retail Pharmacies; Online Pharmacies4) By End User: Hospitals; Ambulatory Surgical CentersCovering: Eli Lilly and Company; Boehringer Ingelheim GmbH; Merck & Co Inc.; Pfizer Inc.; Biocon Ltd. Insulin biosimilars Global Market Report 2024 from The Business ... Read More
-
Global Elderly Care Services Market: Focus on Services, Application, Region, and Competitive Landscape - Analysis and Forecast, 2024-2033
... the diverse needs of older individuals or senior citizens. The core objective of elderly care revolves around addressing the social and personal needs of aging individuals, fostering an environment that allows them to maintain their ... Read More
-
Global Insulin Biosimilars Market - 2023-2030
... period 2023-2030. Biosimilars are equivalent to a reference biologic drug and are developed after the patent on the concerned biologic drug has passed. Biosimilar insulin is a biological replica of an actual insulin and there ... Read More
-
Diabetic Food Market by Product (Bakery Products, Beverages, Confectionery Products), Distribution Channel (Drug Stores/Pharmacies, Grocery Stores, Online Stores) - Global Forecast 2024-2030
... and expected to reach USD 17.15 billion in 2024, at a CAGR 4.82% to reach USD 22.78 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Diabetic Food Market. ... Read More
-
Diabetes Care Devices Market by Use (Point-of-care, Selftest), Product (Blood Glucose Monitoring Devices, Insulin Delivery Devices), Distribution - Global Forecast 2024-2030
... and expected to reach USD 3.10 billion in 2024, at a CAGR 18.58% to reach USD 8.64 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Diabetes Care Devices ... Read More
-
Translational Regenerative Medicine Market by Product Type (Cell Based Product, Gene Therapy Product, Tissue Engineered Product), Application (Cardiovascular, Dermatology, Diabetes) - Global Forecast 2024-2030
... billion in 2023 and expected to reach USD 3.36 billion in 2024, at a CAGR 11.48% to reach USD 6.46 billion by 2030. Global Translational Regenerative Medicine Market FPNV Positioning Matrix The FPNV Positioning Matrix ... Read More
-
Continuous Blood Glucose Monitoring Systems Market by Product (Continuous Glucose Monitoring Systems, Self-Monitoring Blood Glucose Systems), Component (CGM Monitor, CGM Transmitter, Glucose Sensor), Testing Site, Patient Care Setting, Application - Globa
... Blood Glucose Monitoring Systems Market size was estimated at USD 4.50 billion in 2023 and expected to reach USD 4.86 billion in 2024, at a CAGR 8.14% to reach USD 7.79 billion by 2030. FPNV ... Read More
-
Blood Glucose Testing Market by Product (Glucose Meter, Lancets, Test Strips), Distribution Channel (Offline, Online), End-User, Application - Global Forecast 2024-2030
... and expected to reach USD 21.15 billion in 2024, at a CAGR 9.67% to reach USD 36.92 billion by 2030. Global Blood Glucose Testing MarketBlood glucose testing includes devices and supplies used to measure blood ... Read More
-
Digital Biomarkers Market by Type (Hardware, Software), Therapeutic Area (Cardiovascular and metabolic disorders (CVMD), Musculoskeletal disorders, Neurological disorders), End-Use - Global Forecast 2024-2030
... 2023 and expected to reach USD 4.34 billion in 2024, at a CAGR 19.97% to reach USD 13.00 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Digital Biomarkers ... Read More
-
Autoimmune Disease Drugs Market by Indication (Diabetes Mellitus Type 1, Multiple Sclerosis, Rare Diseases), Drug Class (Anti-Inflammatory, Antihyperglycemic, Immunosuppressants), Distribution - Global Forecast 2024-2030
... billion in 2023 and expected to reach USD 116.79 billion in 2024, at a CAGR 7.52% to reach USD 180.67 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the ... Read More
-
Regenerative Medicine Market by Type (Cell-Based Immunotherapy & Cell Therapy Products, Gene Therapy Products, Small Molecule & Biologic), Application (Cardiovascular, Diabetes, Musculoskeletal Disorders) - Global Forecast 2024-2030
... USD 24.01 billion in 2023 and expected to reach USD 28.82 billion in 2024, at a CAGR 20.13% to reach USD 86.73 billion by 2030. Global Regenerative Medicine Market FPNV Positioning Matrix The FPNV Positioning ... Read More
-
Clinical Research Services Market by Services (Clinical Trials, Diagnostic Research, Drug Development Consultancy), Indication (Cardio Vascular Disorders, CNS Disorders, Diabetes), End-User, Deployment - Global Forecast 2024-2030
... USD 57.31 billion in 2023 and expected to reach USD 62.69 billion in 2024, at a CAGR 9.47% to reach USD 108.02 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in ... Read More
-
Microbiome Therapeutics Market by Type (FMT, Microbiome Drugs), Application (C. difficile, Crohn’s disease, Diabetes) - Global Forecast 2024-2030
... USD 156.40 million in 2024, at a CAGR 23.77% to reach USD 564.82 million by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Microbiome Therapeutics Market. It offers a comprehensive ... Read More
-
Auto-Injectors Market by Therapy (Anaphylaxis, Diabetes, Multiple Sclerosis), Product Type (Disposable Auto-Injectors, Reusable Auto-Injectors), Application, End-user - Global Forecast 2024-2030
... reach USD 80.62 billion in 2024, at a CAGR 19.72% to reach USD 237.70 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Auto-Injectors Market. It offers a comprehensive ... Read More
-
Diabetes Diagnostics Market by Diabetes Type (Diabetes I, Diabetes II, Gestational Diabetes), Product (Biochips, Glucose Monitors, Kits), Diabetes Diagnostics Type, End-User - Global Forecast 2024-2030
... billion in 2023 and expected to reach USD 21.91 billion in 2024, at a CAGR 7.80% to reach USD 34.48 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the ... Read More
Research Assistance
